A Home-based Study Using Mobile Technology to Test Whether BI 1358894 is Effective in People With Depression
A Phase II 6-week, Randomized, Double-blinded, Placebo Controlled, Parallel Group Decentralised Clinical Trial to Evaluate Efficacy and Safety of Oral BI 1358894 in Patients With Major Depressive Disorder With Inadequate Response to Antidepressants
Sponsor: Boehringer Ingelheim
Terminated
Recruitment challenges
Other terminated trials from Boehringer Ingelheim
Other Depressive Disorder, Major trials with similar outcome
Listed as NCT04423757, this PHASE2 trial focuses on Depressive Disorder, Major and remains terminated or withdrawn. Sponsored by Boehringer Ingelheim, it has been updated 28 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
28 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jul 2023 — Jul 2024 [monthly]
Terminated PHASE2
-
Jun 2023 — Jul 2023 [monthly]
Terminated PHASE2
-
Oct 2022 — Jun 2023 [monthly]
Terminated PHASE2
▶ Show 23 earlier versions
-
Jul 2022 — Oct 2022 [monthly]
Terminated PHASE2
Status: Active Not Recruiting → Terminated
-
Jun 2022 — Jul 2022 [monthly]
Active Not Recruiting PHASE2
Status: Suspended → Active Not Recruiting
-
May 2022 — Jun 2022 [monthly]
Suspended PHASE2
Status: Terminated → Suspended
-
Apr 2022 — May 2022 [monthly]
Terminated PHASE2
Status: Recruiting → Terminated
-
Mar 2022 — Apr 2022 [monthly]
Recruiting PHASE2
-
Feb 2022 — Mar 2022 [monthly]
Recruiting PHASE2
-
Jan 2022 — Feb 2022 [monthly]
Recruiting PHASE2
-
Dec 2021 — Jan 2022 [monthly]
Recruiting PHASE2
-
Nov 2021 — Dec 2021 [monthly]
Recruiting PHASE2
-
Oct 2021 — Nov 2021 [monthly]
Recruiting PHASE2
-
Sep 2021 — Oct 2021 [monthly]
Recruiting PHASE2
-
Jun 2021 — Sep 2021 [monthly]
Recruiting PHASE2
-
May 2021 — Jun 2021 [monthly]
Recruiting PHASE2
-
Apr 2021 — May 2021 [monthly]
Recruiting PHASE2
-
Mar 2021 — Apr 2021 [monthly]
Recruiting PHASE2
-
Feb 2021 — Mar 2021 [monthly]
Recruiting PHASE2
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE2
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Nov 2020 — Dec 2020 [monthly]
Recruiting PHASE2
-
Oct 2020 — Nov 2020 [monthly]
Recruiting PHASE2
-
Sep 2020 — Oct 2020 [monthly]
Recruiting PHASE2
-
Aug 2020 — Sep 2020 [monthly]
Recruiting PHASE2
-
Jul 2020 — Aug 2020 [monthly]
Recruiting PHASE2
First recorded
Jun 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Boehringer Ingelheim
For direct contact, visit the study record on ClinicalTrials.gov .